Lilia G Diaz, RN | |
280 Jackson Rd, Atco, NJ 08004-1645 | |
(856) 767-5757 | |
Not Available |
Full Name | Lilia G Diaz |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 280 Jackson Rd, Atco, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215207691 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 26NO05571900 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lilia G Diaz, RN 280 Jackson Rd, Atco, NJ 08004-1645 Ph: (856) 767-5757 | Lilia G Diaz, RN 280 Jackson Rd, Atco, NJ 08004-1645 Ph: (856) 767-5757 |
News Archive
Loss of physical strength due to muscle deterioration is a complication for people living with Type 1 diabetes that's often overlooked. New research from McMaster University shows it shouldn't be.
Americans fill about 4.5 billion prescriptions each year, at a cost of more than $323 billion. But what are we actually buying? In 11 states, the top prescriptions are opioid pain pills that are mixtures of acetaminophen and hydrocodone (brand names Vicodin and Norco), according to new data from GoodRx, an online prescription cost service.
In a new analysis of studies conducted following the implementation of the 2010 Healthy Hunger Free Kids Act, researchers find positive effects on the dietary quality of meals served to school-aged children.
A Gold Coast man has been waiting for the last three years for a surgery for his fractured skull. Queensland Health Minister Paul Lucas feels it is been too long a wait. He assured that Queensland Health would be happy to provide appropriate treatment.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
› Verified 3 days ago